• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆鞘氨醇-1-磷酸在肥胖症中升高。

Plasma sphingosine-1-phosphate is elevated in obesity.

机构信息

Integrative Physiology and Metabolism Laboratory, Department of Physiology, Monash University, Clayton, Victoria, Australia.

出版信息

PLoS One. 2013 Sep 6;8(9):e72449. doi: 10.1371/journal.pone.0072449. eCollection 2013.

DOI:10.1371/journal.pone.0072449
PMID:24039766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3765451/
Abstract

BACKGROUND

Dysfunctional lipid metabolism is a hallmark of obesity and insulin resistance and a risk factor for various cardiovascular and metabolic complications. In addition to the well known increase in plasma triglycerides and free fatty acids, recent work in humans and rodents has shown that obesity is associated with elevations in the bioactive class of sphingolipids known as ceramides. However, in obesity little is known about the plasma concentrations of sphinogsine-1-phosphate (S1P), the breakdown product of ceramide, which is an important signaling molecule in mammalian biology. Therefore, the purpose of this study was to examine the impact of obesity on circulating S1P concentration and its relationship with markers of glucose metabolism and insulin sensitivity.

METHODOLOGY/PRINCIPAL FINDINGS: Plasma S1P levels were determined in high-fat diet (HFD)-induced and genetically obese (ob/ob) mice along with obese humans. Circulating S1P was elevated in both obese mouse models and in obese humans compared with lean healthy controls. Furthermore, in humans, plasma S1P positively correlated with total body fat percentage, body mass index (BMI), waist circumference, fasting insulin, HOMA-IR, HbA1c (%), total and LDL cholesterol. In addition, fasting increased plasma S1P levels in lean healthy mice.

CONCLUSION

We show that elevations in plasma S1P are a feature of both human and rodent obesity and correlate with metabolic abnormalities such as adiposity and insulin resistance.

摘要

背景

脂代谢功能障碍是肥胖和胰岛素抵抗的标志,也是各种心血管和代谢并发症的危险因素。除了众所周知的血浆甘油三酯和游离脂肪酸增加外,最近在人类和啮齿动物中的研究表明,肥胖与生物活性鞘脂类(称为神经酰胺)的升高有关。然而,在肥胖症中,关于神经酰胺分解产物鞘氨醇-1-磷酸(S1P)的血浆浓度知之甚少,而 S1P 是哺乳动物生物学中的一种重要信号分子。因此,本研究的目的是研究肥胖对循环 S1P 浓度的影响及其与葡萄糖代谢和胰岛素敏感性标志物的关系。

方法/主要发现:测定高脂肪饮食(HFD)诱导的肥胖和遗传性肥胖(ob/ob)小鼠以及肥胖人群的血浆 S1P 水平。与瘦健康对照组相比,两种肥胖小鼠模型和肥胖人群的循环 S1P 水平均升高。此外,在人类中,血浆 S1P 与体脂肪百分比、体重指数(BMI)、腰围、空腹胰岛素、HOMA-IR、HbA1c(%)、总胆固醇和 LDL 胆固醇呈正相关。此外,在瘦健康小鼠中,空腹会增加血浆 S1P 水平。

结论

我们表明,血浆 S1P 的升高是人类和啮齿动物肥胖的特征,并与肥胖和胰岛素抵抗等代谢异常相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493b/3765451/1ea17cd166fb/pone.0072449.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493b/3765451/04ac723b75ae/pone.0072449.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493b/3765451/b5e4746451bf/pone.0072449.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493b/3765451/1ea17cd166fb/pone.0072449.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493b/3765451/04ac723b75ae/pone.0072449.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493b/3765451/b5e4746451bf/pone.0072449.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493b/3765451/1ea17cd166fb/pone.0072449.g003.jpg

相似文献

1
Plasma sphingosine-1-phosphate is elevated in obesity.血浆鞘氨醇-1-磷酸在肥胖症中升高。
PLoS One. 2013 Sep 6;8(9):e72449. doi: 10.1371/journal.pone.0072449. eCollection 2013.
2
Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome.青少年代谢综合征高危人群血清神经酰胺和炎症介质的变化
Endocrine. 2012 Jun;41(3):442-9. doi: 10.1007/s12020-011-9589-4. Epub 2012 Jan 7.
3
Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.肥胖个体血浆中鞘氨醇-1-磷酸水平升高及其在脂肪细胞中增加纤溶酶原激活物抑制剂-1表达的能力。
Coron Artery Dis. 2013 Dec;24(8):642-50. doi: 10.1097/MCA.0000000000000033.
4
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.患有中度和重度肥胖及代谢综合征的女性中,PYY、胃饥饿素、胆囊收缩素、胃泌素和胰岛素的基础及餐后血浆水平。
J Physiol Pharmacol. 2007 Mar;58 Suppl 1:13-35.
5
S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction.S1P/S1PR3 信号轴可预防肥胖引起的代谢功能障碍。
Adipocyte. 2022 Dec;11(1):69-83. doi: 10.1080/21623945.2021.2021700.
6
Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.银屑病患者循环中鞘氨醇-1-磷酸水平升高,神经酰胺水平降低。
Arch Dermatol Res. 2017 Mar;309(2):79-86. doi: 10.1007/s00403-016-1709-9. Epub 2016 Dec 17.
7
Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate.妊娠期间获得性与预先存在的葡萄糖不耐受的脂质代谢差异:游离脂肪酸和鞘氨醇-1-磷酸的作用。
Lipids Health Dis. 2022 Oct 8;21(1):99. doi: 10.1186/s12944-022-01706-x.
8
Divergent role of sphingosine 1-phosphate on insulin resistance.1-磷酸鞘氨醇在胰岛素抵抗中的不同作用。
Cell Physiol Biochem. 2014;34(1):134-47. doi: 10.1159/000362990. Epub 2014 Jun 16.
9
Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical Nerve-Terminals of Insulin-Resistant Goto-Kakizaki Rats and Diet-Induced Obese Mice.胰岛素抵抗 Goto-Kakizaki 大鼠和饮食诱导肥胖小鼠皮质神经末梢中鞘氨醇-1-磷酸受体的密度发生改变。
Neurochem Res. 2024 Feb;49(2):338-347. doi: 10.1007/s11064-023-04033-4. Epub 2023 Oct 4.
10
Ceramide and Sphingosine 1-Phosphate in Liver Diseases.肝疾病中的神经酰胺和鞘氨醇 1-磷酸。
Mol Cells. 2020 May 31;43(5):419-430. doi: 10.14348/molcells.2020.0054.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
The relationship between plasma sphingosine-1-phosphate, plasma apolipoprotein M, obesity, and the risk of incident type 2 diabetes: a prospective cohort study.血浆鞘氨醇-1-磷酸、血浆载脂蛋白M、肥胖与2型糖尿病发病风险之间的关系:一项前瞻性队列研究。
Int J Obes (Lond). 2025 Aug 26. doi: 10.1038/s41366-025-01890-7.
3
Intracellular Sphingosine-1-Phosphate Induces Lipolysis Through Direct Activation of Protein Kinase C Zeta.

本文引用的文献

1
HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL.高密度脂蛋白(HDL)质量或胆固醇载量:哪个更重要——富含鞘氨醇 1-磷酸的 HDL 成为焦点。
Curr Opin Lipidol. 2013 Aug;24(4):351-6. doi: 10.1097/MOL.0b013e328361f822.
2
Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles.人血浆中鞘氨醇-1-磷酸的分布:与血脂谱的关联
J Lipids. 2012;2012:180705. doi: 10.1155/2012/180705. Epub 2012 Nov 8.
3
The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.
细胞内鞘氨醇-1-磷酸通过直接激活蛋白激酶Cζ诱导脂肪分解。
FASEB J. 2025 Apr 15;39(7):e70528. doi: 10.1096/fj.202403272R.
4
Mechanisms of Lipid-Associated Macrophage Accrual in Metabolically Stressed Adipose Tissue.代谢应激脂肪组织中脂质相关巨噬细胞积聚的机制
Bioessays. 2025 Apr;47(4):e202400203. doi: 10.1002/bies.202400203. Epub 2025 Jan 19.
5
Sphingosine-1-phosphate in the regulation of diabetes mellitus: a scientometric study to an in-depth review.1-磷酸鞘氨醇在糖尿病调节中的作用:一项深入综述的科学计量学研究
Front Endocrinol (Lausanne). 2024 Dec 24;15:1377601. doi: 10.3389/fendo.2024.1377601. eCollection 2024.
6
Metabolic programming of organ-specific natural killer cell responses.器官特异性自然杀伤细胞反应的代谢编程。
Immunol Rev. 2024 May;323(1):8-18. doi: 10.1111/imr.13333. Epub 2024 Apr 17.
7
Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications.肥胖对哮喘气道重塑的影响:病理生理学见解与临床意义
Front Allergy. 2024 Mar 18;5:1365801. doi: 10.3389/falgy.2024.1365801. eCollection 2024.
8
Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort.血浆神经酰胺和其他鞘脂与纵向双种族队列中发生的前驱糖尿病的关系。
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2530-2540. doi: 10.1210/clinem/dgae179.
9
Crosstalk between Serum and Skin Sphingolipids in Psoriasis.血清和皮肤神经酰胺在银屑病中的相互作用。
Int J Mol Sci. 2023 Oct 3;24(19):14872. doi: 10.3390/ijms241914872.
10
Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical Nerve-Terminals of Insulin-Resistant Goto-Kakizaki Rats and Diet-Induced Obese Mice.胰岛素抵抗 Goto-Kakizaki 大鼠和饮食诱导肥胖小鼠皮质神经末梢中鞘氨醇-1-磷酸受体的密度发生改变。
Neurochem Res. 2024 Feb;49(2):338-347. doi: 10.1007/s11064-023-04033-4. Epub 2023 Oct 4.
鞘氨醇-1-磷酸类似物 FTY720 可降低高脂喂养雄性小鼠的肌肉神经酰胺含量并改善葡萄糖耐量。
Endocrinology. 2013 Jan;154(1):65-76. doi: 10.1210/en.2012-1847. Epub 2012 Nov 26.
4
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.2 型糖尿病患者的 LDL 中所含的神经酰胺水平升高,会促进炎症和骨骼肌胰岛素抵抗。
Diabetes. 2013 Feb;62(2):401-10. doi: 10.2337/db12-0686. Epub 2012 Nov 8.
5
Ephedrine activates brown adipose tissue in lean but not obese humans.麻黄碱激活瘦人而非肥胖人群的棕色脂肪组织。
Diabetologia. 2013 Jan;56(1):147-55. doi: 10.1007/s00125-012-2748-1. Epub 2012 Oct 13.
6
Sphingolipid signaling in metabolic disorders.鞘脂代谢信号在代谢性疾病中的作用。
Cell Metab. 2012 Oct 3;16(4):420-34. doi: 10.1016/j.cmet.2012.06.017. Epub 2012 Sep 13.
7
Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.脂肪酸供应过剩对血浆神经酰胺水平的调节:肝脏检测和分泌从头合成神经酰胺的证据。
Diabetologia. 2012 Oct;55(10):2741-2746. doi: 10.1007/s00125-012-2649-3. Epub 2012 Jul 27.
8
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.肥胖症和 2 型糖尿病患者的血浆溶血磷脂酰胆碱水平降低。
PLoS One. 2012;7(7):e41456. doi: 10.1371/journal.pone.0041456. Epub 2012 Jul 25.
9
Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism.量化肝脏对葡萄糖稳态的贡献:人体肝葡萄糖代谢的详细动力学模型。
PLoS Comput Biol. 2012;8(6):e1002577. doi: 10.1371/journal.pcbi.1002577. Epub 2012 Jun 21.
10
Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.鞘氨醇 1-磷酸(S1P)调节胰岛β细胞的葡萄糖刺激胰岛素分泌。
J Biol Chem. 2012 Apr 13;287(16):13457-64. doi: 10.1074/jbc.M111.268185. Epub 2012 Mar 2.